Equities

Pro Medicus Ltd

Pro Medicus Ltd

Actions
Health CareHealth Care Providers
  • Price (AUD)120.12
  • Today's Change0.05 / 0.04%
  • Shares traded5.87m
  • 1 Year change+102.39%
  • Beta1.0630
Data delayed at least 20 minutes, as of May 31 2024 07:10 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Pro Medicus Limited is an Australia-based healthcare informatics company. The Company provides a full range of medical imaging software and services to hospitals, imaging centers and health care groups in Australia, North America and Europe. Its products include Visage RIS, Visage RIS/PACS, Visage 7, Visage Ease Pro and Visage Ease. Its Visage RIS is a radiology information systems (RIS) medical software for practicing of management, training, installation and professional services. Visage RIS capabilities include patient registration, billing, scheduling, typing, HL7 integration, financial reporting, digital dictation and voice recognition integration. Its Visage 7.0 is a healthcare imaging software that provides clinicians with visualization capability for rapidly viewing 2-D, 3-D and 4-D medical images and picture archive and communication system (PACS)/digital imaging software that is sold directly and to original equipment manufacturers (OEM), training, installation and others.

  • Revenue in AUD (TTM)146.20m
  • Net income in AUD69.71m
  • Incorporated1983
  • Employees79.00
  • Location
    Pro Medicus LtdRichmond, 450 Swan StRICHMOND 3121AustraliaAUS
  • Phone+61 39429-8800
  • Fax+61 39429-9455
  • Websitehttps://www.promed.com.au/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Yonyou Network Technology Co Ltd2.09bn-212.41m7.98bn24.95k--3.99--3.82-0.3072-0.30723.042.820.42639.043.10403,645.80-4.162.45-7.685.0950.6158.52-9.765.201.06-7.150.367285.875.774.92-541.28--29.84--
SenseTime Group Inc707.74m-1.34bn8.49bn4.53k--1.76--12.00-0.216-0.2160.11430.7480.09693.390.7581812,532.60-18.47-29.00-20.40-34.6644.0762.39-190.69-255.025.00-6.450.2164---10.5712.94-6.54--25.50--
Altium Ltd425.67m105.14m8.84bn791.0084.3018.5774.5020.770.79480.79483.223.610.68972.183.71--17.0413.8222.0318.7199.06--24.7022.812.69--0.029884.7519.2413.4019.5712.090.581112.49
Persistent Systems Ltd1.77bn196.95m9.36bn19.55k47.9910.5837.035.2971.0771.07638.32322.241.40--6.14--15.5714.5922.2019.6783.8484.5011.1311.05----0.083433.9617.6223.8818.7225.4749.5936.43
Trend Micro Inc2.45bn144.38m9.53bn7.43k64.088.1022.413.90110.46110.461,879.12874.200.604110.014.5134,434,610.003.576.428.6410.6174.4977.005.9113.121.05--0.00143.4511.129.17-64.04-17.6416.23-19.24
Oracle Financial Services Software Ltd1.15bn399.74m11.64bn9.08k29.238.2228.1810.14255.05255.05732.45906.730.6635--5.30--23.1021.6626.3624.60----34.8233.80----0.005497.3411.845.1522.889.88-17.07--
Pro Medicus Limited146.20m69.71m12.54bn79.00179.9778.81160.5085.800.66750.66751.401.520.75167.113.59--35.8429.9840.9235.4499.7199.1847.6844.897.4948.300.009638.9035.3030.2836.4743.510.196637.97
Oracle Corp Japan2.30bn530.91m13.64bn2.40k25.658.0925.095.94433.91433.911,878.591,376.350.9161--18.64100,321,500.0021.1617.4735.0828.9547.0648.2723.1022.88----0.0092.345.694.111.626.06-12.626.01
Capcom Co Ltd1.46bn414.42m14.77bn3.33k27.966.2232.4810.14103.71103.71364.41466.430.66141.616.05--18.8217.1522.7321.2755.5455.7528.4627.164.67--0.058736.1521.038.7918.0728.1518.4231.95
Konami Group Corp3.44bn565.35m15.03bn4.88k25.123.4819.094.37436.50436.502,658.003,152.620.62515.138.79--10.268.1211.939.7544.4241.7616.4213.323.84--0.122933.2214.636.5469.5711.594.2514.87
Cambricon Technologies Corp Ltd136.94m-170.21m15.11bn999.00--13.26--110.37-1.98-1.981.5913.180.11561.100.958660,425.20-14.80-15.77-16.11-17.7967.1854.58-128.00-151.7214.80--0.004---2.7043.3932.47--6.04--
Shanghai Baosight Software Co Ltd2.86bn548.87m16.75bn5.71k35.977.94--5.851.101.105.734.980.6362.812.222,412,369.0012.4011.4622.4720.3834.7932.6219.5016.621.69--0.114980.01-1.7817.2916.8242.15-9.7047.16
Data as of May 31 2024. Currency figures normalised to Pro Medicus Ltd's reporting currency: Australian Dollar AUD

Institutional shareholders

6.40%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 09 May 20241.89m1.82%
Vanguard Investments Australia Ltd.as of 30 Apr 2024909.16k0.87%
BlackRock Fund Advisorsas of 09 May 2024639.25k0.61%
Brown Capital Management LLCas of 31 Dec 2023613.43k0.59%
Colonial First State Investments Ltd.as of 30 Jun 2023605.94k0.58%
DFA Australia Ltd.as of 30 Apr 2024479.01k0.46%
Norges Bank Investment Managementas of 31 Dec 2023462.29k0.44%
BetaShares Capital Ltd.as of 30 Apr 2024439.07k0.42%
Dimensional Fund Advisors LPas of 09 May 2024343.09k0.33%
American Century Investment Management (UK) Ltd.as of 30 Sep 2021300.00k0.29%
More ▼
Data from 30 Sep 2021 - 30 May 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.